Small Biotechnologies Ltd 12438409 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is Technical consultancy Digita Accounts Production Advanced 6.30.9574.0 true 12438409 2022-03-01 2023-02-28 12438409 2023-02-28 12438409 bus:Original 2023-02-28 12438409 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 12438409 bus:Micro-entities 2022-03-01 2023-02-28 12438409 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 12438409 bus:FullAccounts 2022-03-01 2023-02-28 12438409 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 12438409 bus:RegisteredOffice 2022-03-01 2023-02-28 12438409 bus:Director1 2022-03-01 2023-02-28 12438409 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12438409 countries:England 2022-03-01 2023-02-28 12438409 2021-03-01 2022-02-28 12438409 2022-02-28 12438409 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 iso4217:GBP xbrli:pure

Registration number: 12438409

Small Biotechnologies Ltd

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2023

 

Small Biotechnologies Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Small Biotechnologies Ltd

Company Information

Director

Dr Pavel Abdulkin

Registered office

24 Holburn Viaduct
International House
London
EC1A 2BN

Accountants

Tony Jennings FCA CA(SA)
21 Jeavons Lane
Great Cambourne
Cambridge
CB23 6AF

 

Small Biotechnologies Ltd

(Registration number: 12438409)
Balance Sheet as at 28 February 2023

2023
£

2022
£

Fixed assets

19,260

-

Current assets

8,729

4,659

Creditors: Amounts falling due within one year

(6,315)

(5,239)

Net current assets/(liabilities)

2,414

(580)

Total assets less current liabilities

21,674

(580)

Accruals and deferred income

(1,416)

(1,492)

 

20,258

(2,072)

Capital and reserves

20,258

(2,072)

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
24 Holburn Viaduct
International House
London
EC1A 2BN
England

These financial statements were authorised for issue by the director on 27 November 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 0).

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

Small Biotechnologies Ltd

(Registration number: 12438409)
Balance Sheet as at 28 February 2023

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 27 November 2023
 

.........................................
Dr Pavel Abdulkin
Director